Program Indication Phase of Development Comments
SCAI-001 (Cyclosporine A) Dry Eye Syndrome Phase II Phase II completed (24/2)
SCAI-005 (Axitinib) Wet AMD Phase I Phase I completed (25/11)
SCAI-010 Wet AMD Preclinical